Having trouble accessing articles? Reset your cache.

Cytochroma, Mitsubishi Tanabe in CTA018 deal

Cytochroma (Markham, Ontario) granted Mitsubishi Tanabe Pharma (Tokyo:4508; Osaka:4508) an exclusive license to develop and commercialize CTA018 and follow-on compounds

Read the full 202 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE